ArticleScientific reports2025
Machine learning-based estimation of the mild cognitive impairment stage using multimodal physical and behavioral measures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.Journal of medical Internet research · 2026Article
- Article
- Comparison of Sleep Architecture in Individuals Aged 65 to 80 Years With and Without Mild Cognitive Impairment Using Multi-Channel Sleep Monitoring.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Mild cognitive impairment (MCI) is a prodromal stage of dementia, and its early detection is critical for improving clinical outcomes. However, current diagnostic tools such as brain magnetic resonance imaging (MRI) and neuropsychological testing have limited accessibility and scalability. Using machine-learning models, we aimed to evaluate whether multimodal physical and behavioral measures, specifically gait characteristics, body mass composition, and sleep parameters, could serve as digital biomarkers for estimating MCI severity. We recruited 80 patients diagnosed with MCI and classified them into early- and late-stage groups based on their Mini-Mental State Examination scores. Participants underwent clinical assessments, including the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet Korean Version, gait analysis using GAITRite, body composition evaluation via dual-energy X-ray absorptiometry, and polysomnography-based sleep assessment. Brain MRI was also performed to obtain structural imaging data. We evaluated the classification performance across various models, including support vector machines, random forest, multilayer perceptron, and convolutional neural network, using unimodal and multimodal datasets. Machine learning models trained on physical and behavioral data alone achieved a high classification accuracy (AUC up to 94%), comparable to that of MRI-based models, in differentiating early- and late-stage MCI. Combining physical and behavioral and MRI features yielded marginal improvements in the prediction performance. Gait velocity, lean body mass, and sleep efficiency were among the top predictors of cognitive function. Multimodal digital biomarkers or multimodal physical and behavioral signals can effectively estimate MCI severity and may offer a scalable, low-cost approach for early detection and monitoring of cognitive decline in real-world settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.